75 related articles for article (PubMed ID: 21554153)
21. Synthesis of GDP-L-fucose by the human FX protein.
Tonetti M; Sturla L; Bisso A; Benatti U; De Flora A
J Biol Chem; 1996 Nov; 271(44):27274-9. PubMed ID: 8910301
[TBL] [Abstract][Full Text] [Related]
22. Production of GDP-L-fucose, L-fucose donor for fucosyloligosaccharide synthesis, in recombinant Escherichia coli.
Byun SG; Kim MD; Lee WH; Lee KJ; Han NS; Seo JH
Appl Microbiol Biotechnol; 2007 Mar; 74(4):768-75. PubMed ID: 17111133
[TBL] [Abstract][Full Text] [Related]
23. Preparative synthesis of GDP-beta-L-fucose by recombinant enzymes from enterobacterial sources.
Albermann C; Distler J; Piepersberg W
Glycobiology; 2000 Sep; 10(9):875-81. PubMed ID: 10988249
[TBL] [Abstract][Full Text] [Related]
24. An epimerase-reductase in L-fucose synthesis.
Chang S; Duerr B; Serif G
J Biol Chem; 1988 Feb; 263(4):1693-7. PubMed ID: 3338988
[TBL] [Abstract][Full Text] [Related]
25. A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells.
Mabashi-Asazuma H; Kuo CW; Khoo KH; Jarvis DL
Glycobiology; 2014 Mar; 24(3):325-40. PubMed ID: 24362443
[TBL] [Abstract][Full Text] [Related]
26. Expression of genes that control core fucosylation in hepatocellular carcinoma: Systematic review.
Norton PA; Mehta AS
World J Gastroenterol; 2019 Jun; 25(23):2947-2960. PubMed ID: 31249452
[TBL] [Abstract][Full Text] [Related]
27. Biochemical characterization of GDP-L-fucose de novo synthesis pathway in fungus Mortierella alpina.
Ren Y; Perepelov AV; Wang H; Zhang H; Knirel YA; Wang L; Chen W
Biochem Biophys Res Commun; 2010 Jan; 391(4):1663-9. PubMed ID: 20035716
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a cytosolic fucosylation pathway in Dictyostelium.
Gonzalez-Yanes B; Cicero JM; Brown RD; West CM
J Biol Chem; 1992 May; 267(14):9595-605. PubMed ID: 1577798
[TBL] [Abstract][Full Text] [Related]
29. Establishment of a GDP-mannose 4,6-dehydratase (GMD) knockout host cell line: a new strategy for generating completely non-fucosylated recombinant therapeutics.
Kanda Y; Imai-Nishiya H; Kuni-Kamochi R; Mori K; Inoue M; Kitajima-Miyama K; Okazaki A; Iida S; Shitara K; Satoh M
J Biotechnol; 2007 Jun; 130(3):300-10. PubMed ID: 17559959
[TBL] [Abstract][Full Text] [Related]
30. Multienzymatic cascade synthesis of fucosyloligosaccharide via a two-step fermentation strategy in Escherichia coli.
Qin HM; Li S; Zhang YF; Wang JW; Li J; Song S; Lu F; Li Y
Biotechnol Lett; 2016 Oct; 38(10):1747-52. PubMed ID: 27314478
[TBL] [Abstract][Full Text] [Related]
31. Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC.
Kanda Y; Yamane-Ohnuki N; Sakai N; Yamano K; Nakano R; Inoue M; Misaka H; Iida S; Wakitani M; Konno Y; Yano K; Shitara K; Hosoi S; Satoh M
Biotechnol Bioeng; 2006 Jul; 94(4):680-8. PubMed ID: 16609957
[TBL] [Abstract][Full Text] [Related]
32. Core fucosylation of N-linked glycans in leukocyte adhesion deficiency/congenital disorder of glycosylation IIc fibroblasts.
Sturla L; Fruscione F; Noda K; Miyoshi E; Taniguchi N; Contini P; Tonetti M
Glycobiology; 2005 Oct; 15(10):924-34. PubMed ID: 15917429
[TBL] [Abstract][Full Text] [Related]
33. Decreased availability of GDP-L-fucose in a patient with LAD II with normal GDP-D-mannose dehydratase and FX protein activities.
Körner C; Linnebank M; Koch HG; Harms E; von Figura K; Marquardt T
J Leukoc Biol; 1999 Jul; 66(1):95-8. PubMed ID: 10410995
[TBL] [Abstract][Full Text] [Related]
34. Engineering of a mammalian O-glycosylation pathway in the yeast Saccharomyces cerevisiae: production of O-fucosylated epidermal growth factor domains.
Chigira Y; Oka T; Okajima T; Jigami Y
Glycobiology; 2008 Apr; 18(4):303-14. PubMed ID: 18252777
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the specificities of human blood group H gene-specified alpha 1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: evidence for an inverse relationship between alpha 1,2-L-fucosylation of Gal and alpha 1,6-L-fucosylation of asparagine-linked GlcNAc.
Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; Matta KL
Biochemistry; 1996 Jul; 35(27):8914-24. PubMed ID: 8688427
[TBL] [Abstract][Full Text] [Related]
36. Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells.
Zipin A; Israeli-Amit M; Meshel T; Sagi-Assif O; Yron I; Lifshitz V; Bacharach E; Smorodinsky NI; Many A; Czernilofsky PA; Morton DL; Witz IP
Cancer Res; 2004 Sep; 64(18):6571-8. PubMed ID: 15374970
[TBL] [Abstract][Full Text] [Related]
37. Characterization and role of fucose mutarotase in mammalian cells.
Park D; Ryu KS; Choi D; Kwak J; Park C
Glycobiology; 2007 Sep; 17(9):955-62. PubMed ID: 17602138
[TBL] [Abstract][Full Text] [Related]
38. Rescue of Notch signaling in cells incapable of GDP-L-fucose synthesis by gap junction transfer of GDP-L-fucose in Drosophila.
Ayukawa T; Matsumoto K; Ishikawa HO; Ishio A; Yamakawa T; Aoyama N; Suzuki T; Matsuno K
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15318-23. PubMed ID: 22949680
[TBL] [Abstract][Full Text] [Related]
39. Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation.
Huang H; He Y; Li Y; Gu M; Wu M; Ji L
Bioengineered; 2022 Mar; 13(3):5551-5563. PubMed ID: 35184647
[TBL] [Abstract][Full Text] [Related]
40. Development of orally active inhibitors of protein and cellular fucosylation.
Okeley NM; Alley SC; Anderson ME; Boursalian TE; Burke PJ; Emmerton KM; Jeffrey SC; Klussman K; Law CL; Sussman D; Toki BE; Westendorf L; Zeng W; Zhang X; Benjamin DR; Senter PD
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5404-9. PubMed ID: 23493549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
